|
Vaccine Detail
T. cruzi DNA vaccine pUB-ASP-2 |
Vaccine Information |
- Vaccine Name: T. cruzi DNA vaccine pUB-ASP-2
- Target Pathogen: Trypanosoma cruzi
- Target Disease: Chagas disease
- Vaccine Ontology ID: VO_0004376
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- amastigote surface protein-2
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pcDNA3.1 expressed amastigote surface protein 2 (ASP-2 ) (Chou et al., 2010).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000158
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: The absolute number of both IFN-γ+CD8+ T cells and GZM-b+CD8+ T cells in the spleen was significantly higher in pUB-ASP-2 immunized mice. Immunization with pUB-ASP-2 promotes CD8+ T cell activation, and enhances the expression level of IFN-γ and GZM-b in CD8+ T cells (Chou et al., 2010).
- Efficacy: After being challenged with T. cruzi, mice immunized with pUB-ASP-2 developed a lower parasitemia than control pcDNA immunized groups; survival was also prolonged by immunization with pUB-ASP-2. Six out of seven pUB-ASP-2 immunized mice survived until the end of the experiment (Chou et al., 2010).
|
References |
Chou et al., 2010: Chou B, Hiromatsu K, Hisaeda H, Duan X, Imai T, Murata S, Tanaka K, Himeno K. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi. Biochemical and biophysical research communications. 2010; 392(3); 277-282. [PubMed: 20059980].
|
|